ModivCare Debt to Equity Ratio 2010-2024 | MODV
Current and historical debt to equity ratio values for ModivCare (MODV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ModivCare debt/equity for the three months ending September 30, 2024 was 103.63.
| ModivCare Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-09-30 | $1.67B | $-0.02B | -98.19 |
| 2024-06-30 | $1.67B | $0.01B | 175.16 |
| 2024-03-31 | $1.63B | $0.14B | 11.99 |
| 2023-12-31 | $1.61B | $0.16B | 10.32 |
| 2023-09-30 | $1.60B | $0.16B | 10.10 |
| 2023-06-30 | $1.62B | $0.16B | 10.06 |
| 2023-03-31 | $1.59B | $0.35B | 4.53 |
| 2022-12-31 | $1.59B | $0.36B | 4.48 |
| 2022-09-30 | $1.64B | $0.35B | 4.62 |
| 2022-06-30 | $1.68B | $0.38B | 4.39 |
| 2022-03-31 | $1.74B | $0.38B | 4.62 |
| 2021-12-31 | $1.65B | $0.37B | 4.43 |
| 2021-09-30 | $1.73B | $0.40B | 4.29 |
| 2021-06-30 | $1.17B | $0.41B | 2.85 |
| 2021-03-31 | $1.11B | $0.42B | 2.66 |
| 2020-12-31 | $1.01B | $0.41B | 2.46 |
| 2020-09-30 | $0.38B | $0.41B | 0.93 |
| 2020-06-30 | $0.29B | $0.36B | 0.82 |
| 2020-03-31 | $0.47B | $0.33B | 1.43 |
| 2019-12-31 | $0.28B | $0.32B | 0.88 |
| 2019-09-30 | $0.22B | $0.40B | 0.56 |
| 2019-06-30 | $0.21B | $0.39B | 0.54 |
| 2019-03-31 | $0.30B | $0.32B | 0.95 |
| 2018-12-31 | $0.26B | $0.31B | 0.83 |
| 2018-09-30 | $0.33B | $0.38B | 0.87 |
| 2018-06-30 | $0.31B | $0.37B | 0.84 |
| 2018-03-31 | $0.32B | $0.40B | 0.81 |
| 2017-12-31 | $0.37B | $0.34B | 1.10 |
| 2017-09-30 | $0.33B | $0.38B | 0.86 |
| 2017-06-30 | $0.32B | $0.36B | 0.88 |
| 2017-03-31 | $0.34B | $0.36B | 0.97 |
| 2016-12-31 | $0.31B | $0.38B | 0.83 |
| 2016-09-30 | $0.71B | $0.31B | 2.26 |
| 2016-06-30 | $0.70B | $0.33B | 2.11 |
| 2016-03-31 | $0.68B | $0.35B | 1.94 |
| 2015-12-31 | $0.68B | $0.37B | 1.86 |
| 2015-09-30 | $0.88B | $0.31B | 2.82 |
| 2015-06-30 | $0.90B | $0.32B | 2.79 |
| 2015-03-31 | $0.89B | $0.31B | 2.92 |
| 2014-12-31 | $0.95B | $0.22B | 4.28 |
| 2014-09-30 | $0.48B | $0.18B | 2.74 |
| 2014-06-30 | $0.49B | $0.18B | 2.75 |
| 2014-03-31 | $0.28B | $0.16B | 1.76 |
| 2013-12-31 | $0.27B | $0.15B | 1.82 |
| 2013-09-30 | $0.28B | $0.15B | 1.91 |
| 2013-06-30 | $0.28B | $0.14B | 2.03 |
| 2013-03-31 | $0.28B | $0.13B | 2.21 |
| 2012-12-31 | $0.27B | $0.12B | 2.30 |
| 2012-09-30 | $0.29B | $0.12B | 2.50 |
| 2012-06-30 | $0.28B | $0.12B | 2.45 |
| 2012-03-31 | $0.28B | $0.11B | 2.44 |
| 2011-12-31 | $0.27B | $0.11B | 2.48 |
| 2011-09-30 | $0.28B | $0.10B | 2.70 |
| 2011-06-30 | $0.29B | $0.10B | 2.89 |
| 2011-03-31 | $0.29B | $0.09B | 3.11 |
| 2010-12-31 | $0.30B | $0.09B | 3.36 |
| 2010-09-30 | $0.32B | $0.08B | 3.78 |
| 2010-06-30 | $0.31B | $0.08B | 3.95 |
| 2010-03-31 | $0.32B | $0.07B | 4.46 |
| 2009-12-31 | $0.32B | $0.06B | 5.15 |
| 2009-09-30 | $0.34B | $0.06B | 6.07 |
| 2009-06-30 | $0.33B | $0.05B | 6.55 |
| 2009-03-31 | $0.33B | $0.04B | 7.49 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.223B | $2.756B |
| ModivCare Inc. is a technology-enabled healthcare services company. It provides a suite of integrated supportive care solutions for public and private payors and their patients. ModivCare Inc., formerly known as The Providence Service Corporation, is based in DENVER. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $91.424B | 11.34 |
| Cencora (COR) | United States | $47.484B | 17.51 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| Natera (NTRA) | United States | $21.401B | 0.00 |
| ICON (ICLR) | Ireland | $16.136B | 14.37 |
| Viatris (VTRS) | United States | $15.576B | 4.80 |
| Avantor (AVTR) | United States | $13.422B | 20.12 |
| Revvity (RVTY) | United States | $13.376B | 23.24 |
| CochLear (CHEOY) | Australia | $12.844B | 0.00 |
| BioMerieux (BMXMF) | France | $12.666B | 0.00 |
| Solventum (SOLV) | United States | $11.583B | 0.00 |
| Medpace Holdings (MEDP) | United States | $9.789B | 27.58 |
| Doximity (DOCS) | United States | $9.620B | 56.63 |
| Charles River Laboratories (CRL) | United States | $9.516B | 18.39 |
| HealthEquity (HQY) | United States | $8.966B | 48.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.758B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.885B | 32.05 |
| Life Times (LTH) | United States | $5.085B | 33.66 |
| Sotera Health (SHC) | United States | $3.855B | 20.62 |
| Organon (OGN) | United States | $3.757B | 3.79 |
| BrightSpring Health Services (BTSG) | United States | $3.247B | 69.07 |
| Surgery Partners (SGRY) | United States | $2.892B | 32.97 |
| PACS (PACS) | United States | $2.606B | 0.00 |
| Concentras Parent (CON) | United States | $2.581B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.375B | 0.00 |
| Premier (PINC) | United States | $2.143B | 11.15 |
| Alignment Healthcare (ALHC) | United States | $2.126B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.952B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.616B | 42.40 |
| Teladoc Health (TDOC) | United States | $1.537B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.255B | 12.28 |
| CareDx (CDNA) | United States | $1.183B | 0.00 |
| Progyny (PGNY) | United States | $1.164B | 23.57 |
| Establishment Labs Holdings (ESTA) | $1.050B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.954B | 6.46 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Embecta (EMBC) | United States | $0.778B | 5.18 |
| SBC Medicals (SBC) | United States | $0.677B | 0.00 |
| Agilon Health (AGL) | United States | $0.655B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.647B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.536B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.425B | 0.00 |
| DocGo (DCGO) | United States | $0.410B | 15.46 |
| Enhabit (EHAB) | United States | $0.366B | 31.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.326B | 0.00 |
| LifeMD (LFMD) | United States | $0.241B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.209B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Biodesix (BDSX) | United States | $0.180B | 0.00 |
| Nutex Health (NUTX) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.100B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.25 |
| MultiPlan (MPLN) | United States | $0.084B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.043B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.08 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.020B | 0.00 |
| Oncology Institute (TOI) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |